Chelsea Therapeutics (CHTP) Tops Q2 EPS by 4c
- Oil jumps 8 percent, biggest three-day surge since 1990
- SunTrust Robinson Humphrey Upgrades Twitter, Inc. (TWTR) to Buy
- After Hours Stocks Movers 08/31: (TRVN) (MTRX) (SUNE) Higher; (ADEP) Lower (more...)
- Amicus Therapeutics (FOLD) to Acquire Scioderm in ~$950M Deal
- Wall Street's worst month in three years ends on a sour note
Chelsea Therapeutics (NASDAQ: CHTP) reported Q2 EPS of ($0.21), $0.04 better than the analyst estimate of ($0.25).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Matrix Service (MTRX) Tops Q4 EPS by 13c
- Internet Gold - Golden Lines (IGLD) Reports Q2 Loss of NIS0.65/Share
- Zoe's Kitchen (ZOES) Tops Q2 EPS by 1c, Comps Up 5.6%, Updates Outlook
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!